Enzyme may predict coronary artery calcification

Elevated levels of serum alkaline phosphatase in hemodialysis (HD) patients may predict coronary artery calcification (CAC), which is associated with cardiovascular and mortality in this population.

Originally published on Renal and Urology News - World Review For Urologists and Nephrologists.

Click here to register to receive Renal and Urology News conference highlights by email

In a study of 137 HD patients, Ronney Shantouf, MD, of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center in Torrance, Californioa, and colleagues found that a calcium artery calcification score (CACS) of 400 or more is five times more likely to occur among patients in the highest tertile of serum alkaline phosphatase (120 mg/dL or higher) compared with those in the second tertile (reference; 85-119 mg/dL), after adjusting for age, gender, presence of diabetes mellitus, Charlson comorbidity score, dialysis vintage, interleukin-6, and serum glutamic oxaloacetic transaminase. The researchers observed no association between the first quartile of serum alkaline phosphatase and the likelihood of a CACS of 400 or more.

The mean CACS for patients with a serum alkaline phosphatase level of 120 mg/dL or higher was about twice that of subjects with lower levels.

More news from the National Kidney Foundation 2009 Spring Clinical Meetings

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus